publication date: Dec. 21, 2010

In this issue: 

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market;

Bush Appoints Lander To NCAB;

IOM Report Links Agent Orange, CLL;

FDA Puts Clinical Hold On Gene Therapy Trials;

US Oncology Clarifies Role of Pharmacy Committee;

Funding Opportunities

(8-page issue).

Download (PDF 258KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.